- Home
- PAVM vs EVGN Comparison
PAVM vs EVGN Comparison
Compare PAVM & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAVM | EVGN |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | Israel |
| Employees | 107 | N/A |
| Industry | Medical/Dental Instruments | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7M | 9.1M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | PAVM | EVGN |
|---|---|---|
| Price | $10.63 | $0.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $510.00 | $3.50 |
| AVG Volume (30 Days) | 37.4K | ★ 267.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $450.56 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.21 | $0.73 |
| 52 Week High | $28.44 | $2.42 |
Technical Indicators
Market Signals| Indicator | PAVM | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 59.74 | 29.12 |
| Support Level | $0.39 | N/A |
| Resistance Level | $10.97 | $1.23 |
| Average True Range (ATR) | 0.83 | 0.05 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 78.82 | 13.64 |
Price Performance
Historical ComparisonAbout PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.